If u block out the short term noise (lev exiting and ABC report and Scott Pape selling?) and look at the business itself, ud be glad in the long term u bought in at this price imo..
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%